In the A549 human lung cancer cell line, eriodictyol induced mitochondrial apoptosis and G2/M cell cycle arrest and inhibited mammalian target of rapamycin (mTOR)/PI3K/AKT cascade [117]. The gene discussed is MTOR; the disease is lung carcinoma.